These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 25007342)
1. Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. Sun NX; Ye C; Zhao Q; Zhang Q; Xu C; Wang SB; Jin ZJ; Sun SH; Wang F; Li W PLoS One; 2014; 9(7):e100340. PubMed ID: 25007342 [TBL] [Abstract][Full Text] [Related]
2. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer. Ding M; Zhang H; Li Z; Wang C; Chen J; Shi L; Xu D; Gao Y Clin Exp Pharmacol Physiol; 2015 May; 42(5):458-64. PubMed ID: 25739318 [TBL] [Abstract][Full Text] [Related]
3. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway. Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop. Song H; Liu Y; Jin X; Liu Y; Yang Y; Li L; Wang X; Li G J Cell Mol Med; 2019 Sep; 23(9):6098-6111. PubMed ID: 31273925 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Yang F; Zhang L; Huo XS; Yuan JH; Xu D; Yuan SX; Zhu N; Zhou WP; Yang GS; Wang YZ; Shang JL; Gao CF; Zhang FR; Wang F; Sun SH Hepatology; 2011 Nov; 54(5):1679-89. PubMed ID: 21769904 [TBL] [Abstract][Full Text] [Related]
6. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
7. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma. Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J BJU Int; 2016 Feb; 117(2):351-62. PubMed ID: 24612432 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. Wu Y; Zhang L; Zhang L; Wang Y; Li H; Ren X; Wei F; Yu W; Liu T; Wang X; Zhou X; Yu J; Hao X Int J Oncol; 2015; 46(6):2586-94. PubMed ID: 25901533 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
10. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer. Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma. Niu G; Zhuang H; Li B; Cao G J BUON; 2018; 23(1):157-162. PubMed ID: 29552776 [TBL] [Abstract][Full Text] [Related]
12. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960 [TBL] [Abstract][Full Text] [Related]
13. LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2. Zhang C; Shao S; Zhang Y; Wang L; Liu J; Fang F; Li P; Wang B Life Sci; 2020 Feb; 243():117295. PubMed ID: 31927050 [TBL] [Abstract][Full Text] [Related]
14. LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression. Yang ZY; Yang F; Zhang YL; Liu B; Wang M; Hong X; Yu Y; Zhou YH; Zeng H Cancer Biomark; 2017; 18(1):95-104. PubMed ID: 27983539 [TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Hirata H; Hinoda Y; Shahryari V; Deng G; Nakajima K; Tabatabai ZL; Ishii N; Dahiya R Cancer Res; 2015 Apr; 75(7):1322-31. PubMed ID: 25600645 [TBL] [Abstract][Full Text] [Related]
16. Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma. Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Wu Q; Tan JH; Wu DM; Lu J; Zheng YL J Cell Biochem; 2018 Feb; 119(2):1827-1840. PubMed ID: 28796375 [TBL] [Abstract][Full Text] [Related]
17. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10. Qi Y; Ooi HS; Wu J; Chen J; Zhang X; Tan S; Yu Q; Li YY; Kang Y; Li H; Xiong Z; Zhu T; Liu B; Shao Z; Zhao X Oncotarget; 2016 Mar; 7(11):12693-703. PubMed ID: 26871474 [TBL] [Abstract][Full Text] [Related]
18. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Wang C; Liu X; Chen Z; Huang H; Jin Y; Kolokythas A; Wang A; Dai Y; Wong DT; Zhou X Mol Carcinog; 2013 Mar; 52(3):229-36. PubMed ID: 22161744 [TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer. Fang J; Zhang M; Li Q Am J Med Sci; 2011 Sep; 342(3):198-204. PubMed ID: 21629038 [TBL] [Abstract][Full Text] [Related]